X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1715) 1715
Newsletter (29) 29
Book Chapter (7) 7
Magazine Article (7) 7
Newspaper Article (5) 5
Transcript (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
imiquimod (1344) 1344
humans (1201) 1201
index medicus (907) 907
dermatology (739) 739
female (702) 702
male (615) 615
aminoquinolines - administration & dosage (530) 530
administration, topical (422) 422
treatment outcome (418) 418
animals (404) 404
aminoquinolines - therapeutic use (383) 383
middle aged (379) 379
aged (322) 322
skin neoplasms - drug therapy (311) 311
adult (308) 308
mice (293) 293
care and treatment (291) 291
antineoplastic agents - administration & dosage (277) 277
skin (270) 270
administration, cutaneous (245) 245
adjuvants, immunologic - administration & dosage (236) 236
immunology (234) 234
cancer (226) 226
antineoplastic agents - therapeutic use (208) 208
skin neoplasms - pathology (202) 202
imiquimod 5-percent cream (190) 190
psoriasis (189) 189
topical imiquimod (182) 182
aminoquinolines - adverse effects (177) 177
drug therapy (169) 169
aged, 80 and over (167) 167
inflammation (166) 166
surgery (165) 165
immunotherapy (164) 164
adjuvants, immunologic - therapeutic use (159) 159
dosage and administration (156) 156
photodynamic therapy (152) 152
double-blind (151) 151
melanoma (151) 151
therapy (148) 148
dendritic cells (147) 147
research (147) 147
health aspects (145) 145
cytokines (144) 144
actinic keratosis (142) 142
skin cancer (141) 141
analysis (138) 138
pharmacology & pharmacy (135) 135
immune-response modifier (134) 134
oncology (127) 127
toll-like receptors (127) 127
carcinoma, basal cell - drug therapy (122) 122
disease models, animal (120) 120
cream (118) 118
basal cell carcinoma (116) 116
follow-up studies (116) 116
5-percent cream (111) 111
aminoquinolines - pharmacology (110) 110
interferon (108) 108
drug administration schedule (102) 102
mice, inbred balb c (100) 100
skin diseases (100) 100
basal-cell carcinoma (99) 99
condylomata acuminata - drug therapy (98) 98
expression (96) 96
efficacy (94) 94
ointments (94) 94
mice, inbred c57bl (93) 93
immune response (92) 92
immune system (91) 91
adolescent (90) 90
disease (90) 90
skin - pathology (89) 89
keratosis, actinic - drug therapy (86) 86
management (86) 86
infectious diseases (84) 84
squamous-cell carcinoma (84) 84
warts (81) 81
activation (79) 79
cells (78) 78
medicine (77) 77
skin neoplasms - therapy (77) 77
adjuvants, immunologic - adverse effects (75) 75
antineoplastic agents - adverse effects (75) 75
t cells (75) 75
photochemotherapy (74) 74
cryotherapy (73) 73
psoriasis - drug therapy (73) 73
diagnosis (72) 72
medicine, research & experimental (72) 72
biopsy (71) 71
genital warts (71) 71
lymphocytes (71) 71
lymphocytes t (71) 71
toll-like receptor 7 - agonists (71) 71
child (70) 70
combined modality therapy (70) 70
psoriasis - pathology (70) 70
tumors (70) 70
human papillomavirus (69) 69
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1731) 1731
German (24) 24
French (6) 6
Russian (3) 3
Japanese (2) 2
Spanish (2) 2
Chinese (1) 1
Italian (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of pharmaceutical sciences, ISSN 0928-0987, 2018, Volume 125, pp. 223 - 231
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2015, Volume 2016, Issue 9, p. CD007924
Background This is an updated version of a review first published in theCochrane Database of Systematic Reviews, Issue 4, in 2011. Vulval intraepithelial... 
Imiquimod | Antineoplastic Agents | Cidofovir | Randomized Controlled Trials as Topic | Organophosphonates | Vulvar Neoplasms | Gynaecology | Vagina/vulva | Gynaecological | Carcinoma in Situ | Anticarcinogenic Agents | Cytosine | Indoles | Medicine General & Introductory Medical Sciences | Administration, Topical | CANCER OF THE VULVA | Aminoquinolines | Cancer | Strategies and implementation for pre‐malignant changes | Aminoquinolines [administration & dosage; adverse effects] | Carcinoma in Situ [pathology; therapy] | PHOTODYNAMIC THERAPY | Anticarcinogenic Agents [administration & dosage] | Humans | Antineoplastic Agents [administration & dosage; adverse effects] | TOPICAL IMIQUIMOD | HUMAN-PAPILLOMAVIRUS | NATURAL-HISTORY | Indoles [administration & dosage] | WOMEN | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | VIN 2/3 | SQUAMOUS-CELL CARCINOMA | Adult | Female | QUALITY-OF-LIFE | Vulvar Neoplasms [pathology; therapy] | CLINICAL-RESPONSES | Cytosine - analogs & derivatives | Carcinoma in Situ - pathology | Aminoquinolines - administration & dosage | Cytosine - administration & dosage | Antineoplastic Agents - administration & dosage | Carcinoma in Situ - therapy | Indoles - administration & dosage | Organophosphonates - administration & dosage | Vulvar Neoplasms - pathology | Vulvar Neoplasms - therapy | Anticarcinogenic Agents - administration & dosage | Antineoplastic Agents - adverse effects | Aminoquinolines - adverse effects
Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 11, pp. 1509 - 1516
Highlights • GTL001 is a bivalent CyaA-HPV16 E7/CyaA-HPV18 E7 therapeutic vaccine. • GTL001-induced effector and prophylactic memory T-cell responses eradicate... 
Allergy and Immunology | Tumour-associated antigen | Tumour model | Human papillomavirus | Therapeutic vaccine | Cervical cancer | Memory T-cell response | MEDICINE, RESEARCH & EXPERIMENTAL | METAANALYSIS | DENDRITIC CELLS | ADENYLATE-CYCLASE TOXIN | IMMUNOLOGY | CUTTING EDGE | IMIQUIMOD | IMMUNIZATION | IMMUNE-SYSTEM | E7 ONCOPROTEIN | BORDETELLA-PERTUSSIS | ESTABLISHED TUMORS | Oncogene Proteins, Viral - administration & dosage | Adjuvants, Immunologic - administration & dosage | Neoplasm Proteins - administration & dosage | Ovalbumin - immunology | Papillomavirus Vaccines - genetics | Neoplasm Proteins - immunology | Papillomavirus E7 Proteins - immunology | Drug Carriers - administration & dosage | Vaccines, Synthetic - immunology | Adenylate Cyclase Toxin - genetics | Papillomavirus E7 Proteins - genetics | Antigens, Neoplasm - administration & dosage | Cancer Vaccines - genetics | Melanoma - prevention & control | DNA-Binding Proteins - administration & dosage | Female | Oncogene Proteins, Viral - genetics | Neoplasm Proteins - genetics | Papillomavirus Vaccines - administration & dosage | Disease Models, Animal | Injections, Intradermal | Ovalbumin - genetics | Antigens, Neoplasm - genetics | Papillomavirus Infections - complications | DNA-Binding Proteins - immunology | Ovarian Neoplasms - prevention & control | Antigens, Neoplasm - immunology | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | Vaccines, Synthetic - genetics | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Adenylate Cyclase Toxin - administration & dosage | DNA-Binding Proteins - genetics | Cancer Vaccines - immunology | Animals | Ovalbumin - administration & dosage | Papillomavirus E7 Proteins - administration & dosage | Immunologic Memory | Papillomavirus Vaccines - immunology | T-Lymphocytes - immunology | Oncogene Proteins, Viral - immunology | Vaccines, Synthetic - administration & dosage | Antigens | Care and treatment | Vaccines | T cells | Health aspects | Papillomavirus infections | Tumors | Cancer | Peptides | Stock options | Dendritic cells | Cloning | Melanoma | Amino acids | Employees | T cell receptors | Infections | Experiments | Proteins | Cellular biology
Journal Article
European Journal of Immunology, ISSN 0014-2980, 11/2012, Volume 42, Issue 11, pp. 3049 - 3061
Journal Article
Cancer control, ISSN 1073-2748, 01/2016, Volume 23, Issue 1, pp. 12 - 20
Background: Locoregional advanced melanoma poses a complex clinical challenge that requires a multi-disciplinary, patient-centered approach. Numerous agents... 
ROSE-BENGAL | INTERLEUKIN-2 | PHASE-II TRIAL | DNA-LIPOSOME COMPLEXES | BACILLE CALMETTE-GUERIN | IN-TRANSIT MELANOMA | TOPICAL DIPHENCYPRONE IMMUNOTHERAPY | MALIGNANT-MELANOMA | LENTIGO MALIGNA | DIRECT GENE-TRANSFER | ELECTROCHEMOTHERAPY | ONCOLOGY | ALLOVECTIN-7 | IMIQUIMOD | Molecular targeted therapy | Evaluation | Care and treatment | Melanoma
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 13, pp. 1549 - 1555
Abstract Immunotherapy has emerged as a promising treatment strategy for the control of HPV-associated malignancies. Various therapeutic HPV vaccines have... 
Allergy and Immunology | Dendritic cell | CRT/E7 | GM-CSF | Immunotherapy | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOLOGY | TUMORS | CERVICAL INTRAEPITHELIAL NEOPLASIA | IMIQUIMOD | TRIAL | POTENT | DNA VACCINE | ANTITUMOR IMMUNITY | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Papillomavirus Vaccines - therapeutic use | Cancer Vaccines - administration & dosage | Dendritic Cells - immunology | Mice, Inbred C57BL | Vaccination | Administration, Intravaginal | Combined Modality Therapy | Injections, Intramuscular | Antigen-Presenting Cells - immunology | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Animals | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Cross-Priming - immunology | Female | Mice | Vaginal Neoplasms - therapy | CD8-Positive T-Lymphocytes - immunology | Papillomavirus Vaccines - administration & dosage | Uterine Cervical Neoplasms - therapy | Antigens | Local government | Dendritic cells | Analysis | Macrophage colony stimulating factor | T cells | Macrophages | Papillomavirus infections | Cytokines | Melanoma | Clinical trials | Cytotoxicity | Vaccines | Cell adhesion & migration | Proteins | Studies | Human papillomavirus | Lymphocytes | Laboratory animals | Cervical cancer | Binding sites | Deoxyribonucleic acid--DNA | Immune system | Tumors | Index Medicus | CRT | dendritic cell | immunotherapy
Journal Article
Vaccine, ISSN 0264-410X, 2009, Volume 27, Issue 17, pp. 2326 - 2334
.... Needle-free administration might facilitate vaccine implementation, especially in developing countries... 
Allergy and Immunology | Rectal and vaginal immunization | Human papillomavirus virus-like particles | Mucosal immunity | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | FEMALE GENITAL-TRACT | VACCINE | CERVICAL-CANCER | ENHANCED MUCOSAL | IMMUNOLOGY | B-SUBUNIT | SYSTEMIC IMMUNE-RESPONSES | CUTTING EDGE | MOUSE MODEL | MUCOSAL IMMUNIZATION | Oncogene Proteins, Viral - administration & dosage | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | Imidazoles - administration & dosage | Administration, Intravaginal | Administration, Rectal | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | Capsid Proteins - immunology | Female | Papillomavirus Vaccines - administration & dosage | Rectum - secretion | Cholera Toxin - administration & dosage | Lipid A - administration & dosage | Vagina - secretion | Capsid Proteins - administration & dosage | Antibodies, Viral - physiology | Animals | Papillomavirus Infections - prevention & control | Antibody Formation - drug effects | Mouth - secretion | Mice | Oncogene Proteins, Viral - immunology | Vaccines, Synthetic - administration & dosage | Nonoxynol - administration & dosage | Papillomaviruses | Developing countries | Lipids | Immunization | Cholera toxin | Imiquimod | Human papillomavirus | Teenagers | Vaccines | Feces | Developing countries--LDCs | Cancer | Index Medicus
Journal Article
12.